Skip to main content
Springer logoLink to Springer
. 2018 Sep 22;32(12):1183. doi: 10.1007/s40263-018-0574-9

Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

Mark Gudesblatt 1, Karl Wissemann 1, Myassar Zarif 1, Barbara Bumstead 1, Lori Fafard 1, Jeffrey Wilken 2, Karen Blitz 1, Marijean Buhse 1, Sourav Santra 3, Christophe Hotermans 3, Lily Lee 3,
PMCID: PMC6828358  PMID: 30244406

Correction to: CNS Drugs 10.1007/s40263-018-0553-1

An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 24 August 2018. An error was subsequently identified in the article, and the following correction should be noted:

Author listing: The name of the second author, which previously read:

‘Karl Wisseman’

Should read:

‘Karl Wissemann’.

The original article has been corrected.


Articles from CNS Drugs are provided here courtesy of Springer

RESOURCES